Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» migraines
migraines
Amgen's new migraine drug hits insurance hurdles
Reuters
Thu, 07/26/18 - 07:41 pm
Amgen
migraines
Aimovig
insurers
Prior authorization limits would be 'reasonable' for CGRP drugs, ICER says
Biopharma Dive
Thu, 07/5/18 - 07:44 pm
insurers
ICER
migraines
CGRP
coverage limits
Amgen, Novartis 'overwhelmed' by early interest in migraine drug Aimovig: expert
Fierce Pharma
Wed, 07/4/18 - 10:01 am
migraines
Amgen
Novartis
Aimovig
Impel NeuroPharma readies trial for intranasal drug-device migraine treatment
Drug Delivery Business News
Fri, 06/22/18 - 07:50 pm
Impel NeuroPharma
FDA
INP104
migraines
intra-nasal drug delivery
Teva to Discontinue Trial of Fremanezumab in Chronic Cluster Headache
CP Wire
Fri, 06/15/18 - 09:16 am
Teva Pharmaceutical
fremanezumab
cluster headaches
migraines
Allergan's Migraine Prevention Drug Meets Primary Endpoints in Ph Iib/III Study
CP Wire
Mon, 06/11/18 - 09:15 am
migraines
Allergan
atogepant
Migraine Breakthrough: Not So Fast
Forbes
Wed, 06/6/18 - 09:49 pm
Amgen
Novartis
Aimovig
migraines
adults
monoclonal antibodies
Thanks to lower-than-expected price, ICER backs Amgen's Aimovig—but only after other meds fail
Fierce Pharma
Fri, 06/1/18 - 11:40 am
Amgen
ICER
Aimovig
migraines
Will Amgen’s migraine win and 5th thumbs-up for Prolia drive enough growth? Nope, says analyst
Fierce Pharma
Tue, 05/22/18 - 06:06 pm
Amgen
FDA
Aimovig
migraines
Prolia
Migraine prevention drug could be worth $1 to $2 billion over next five years: Wall Street analyst
CNBC
Sat, 05/19/18 - 11:30 am
migraines
Amgen
Novartis
Aimovig
Amgen’s new migraine drug will cost 30 percent less than Wall Street expected
Stat
Thu, 05/17/18 - 09:48 pm
Amgen
Novartis
migraines
Aimovig
drug pricing
Amgen's Aimovig won its first-in-class migraine nod. Will payers step up to the $6,900 price?
Fierce Pharma
Thu, 05/17/18 - 09:42 pm
Amgen
Novartis
Aimovig
FDA
migraines
Lilly's CGRP drug succeeds in 'worst kind of migraine'
Biopharma Dive
Tue, 05/15/18 - 09:09 pm
Eli Lilly
cluster headaches
migraines
galcanezumab
Migraine drug delay would compound Teva's troubles
Reuters
Thu, 05/3/18 - 11:05 pm
Teva Pharmaceutical
migraines
fremanezumab
Eyeing blockbuster migraine market, Allergan unloads second set of positive PhIII results for ubrogepant
Endpoints
Fri, 04/27/18 - 10:09 am
Allergan
ubrogepant
migraines
clinical trials
New Data For Alder BioPharmaceuticals' Eptinezumab Shows Long-Term Reduction in Episodic Migraine
CP Wire
Wed, 04/25/18 - 11:06 am
Alder BioPharmaceutical
eptinezumab
migraines
Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
Reuters
Tue, 04/24/18 - 10:47 pm
Express Scripts
migraines
PBMs
Amgen
Eli Lilly
Racing Allergan, Biohaven Touts Migraine Drug Data, But Shares Sink
Xconomy
Mon, 03/26/18 - 09:54 am
Allergan
Biohaven Pharmaceuticals
migraines
rimegepant
Will Teva's Fremanezumab Be Delayed due to Troubles at Celltrion?
Market Realist
Mon, 03/26/18 - 09:43 am
Teva Pharmaceutical
fremanezumab
Celltrion
migraines
Migraine maven Lilly finds 'understanding gap' between patients, nonpatients in new survey
Fierce Pharma
Mon, 03/5/18 - 09:45 am
migraines
Eli Lilly
patients
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »